Table 1.
General baseline characteristics of subjects who received either C. sativus or placebo
| Variables |
Crocus sativus groupa (n=40) |
Placebo groupb (n=40) |
p-valuec | |
|---|---|---|---|---|
| Age (year) | 55.2±7.3 | 53±10.6 | 0.61 | |
| Sex | Male n(%) |
20 (50) | 16 (40) | 0.51 |
| Female n(%) |
20 (50) | 24 (60) | ||
| Height (cm) | 162±9.9 | 163.7±8.3 | 0.41 | |
| Weight (kg) | 75.3±12.8 | 80.3±12.8 | 0.08 | |
| BMI (kg/m2) | 29.3±4.9 | 30.5±4.7 | 0.25 | |
| WC (cm) | 106±9.5 | 107.8±12.9 | 0.75 | |
| Duration of T2D (year) | 7.8±5.4 | 6.6±6.1 | 0.13 | |
| Types of hypoglycemic drugs | Metformin n(%) |
4 (10) | 6 (15) | 0.454 |
| Metformin+ glibenclamide n (%) |
8 (20) | 13 (32.5) | ||
| Metformin+ glibenclamide n(%) |
10 (25) | 8 (20) | ||
| Other drugs n (%) |
18 (45) | 13 (32.5) | ||
Abbreviations: BMI, Body Mass Index; WC, Waist Circumference. All quantitative values are expressed as means±SDs. All qualitative values are expressed as numbers and percentages (%).
a
Received 100 mg Crocus sativus per day during the study.
b
Received 100 mg placebo per day during the study.
c
Obtained from independent-samples t test for quantitative values and Chi-square for qualitative values.